PROCEPT BioRobotics Corporation (PRCT) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
PRCT Revenue Growth
Revenue Breakdown
PRCT's revenue distribution by segment and geography
By Geography
PRCT Revenue Analysis (2019–2025)
As of May 6, 2026, PROCEPT BioRobotics Corporation (PRCT) generated trailing twelve-month (TTM) revenue of $322.0 million, reflecting exceptional growth of +20.2% year-over-year. The most recent quarter (Q1 2026) recorded $83.1 million in revenue, up 8.8% sequentially.
Looking at the longer-term picture, PRCT's 5-year compound annual growth rate (CAGR) stands at +109.0%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $308.1 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including ISRG (+21.4% YoY), NVCR (+8.5% YoY), and NTRA (+38.2% YoY), PRCT has underperformed the peer group in terms of revenue growth. Compare PRCT vs ISRG →
PRCT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PRCTCurrent | $322M | +20.2% | +109.0% | -33.7% | |
 ISRG | $10.1B | +21.4% | +18.2% | 29.3% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 NTRA | $1.7B | +38.2% | +41.2% | -13.1% | |
 TNDM | $1.0B | -4.2% | +15.3% | -7.7% | |
 NVS | $54.8B | +5.3% | +1.9% | 31.2% |
PRCT Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $308.1M | +37.2% | $196.2M | 63.7% | $-103,859,000 | -33.7% |
| 2024 | $224.5M | +64.8% | $137.1M | 61.1% | $-96,614,000 | -43.0% |
| 2023 | $136.2M | +81.6% | $71.0M | 52.2% | $-109,170,000 | -80.2% |
| 2022 | $75.0M | +117.6% | $37.1M | 49.4% | $-80,724,000 | -107.6% |
| 2021 | $34.5M | +346.7% | $15.9M | 46.0% | $-54,164,000 | -157.1% |
| 2020 | $7.7M | +25.1% | $-1,255,000 | -16.3% | $-47,802,000 | -619.4% |
| 2019 | $6.2M | - | $-1,885,000 | -30.6% | $-43,550,000 | -705.9% |
See PRCT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PRCT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PRCT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPRCT — Frequently Asked Questions
Quick answers to the most common questions about buying PRCT stock.
Is PRCT's revenue growth accelerating or slowing?
PRCT revenue is accelerating at +20.2% year-over-year, exceeding the 5-year CAGR of +109.0%. TTM revenue reached $322M. Growth momentum has increased versus prior periods.
What is PRCT's long-term revenue growth rate?
PROCEPT BioRobotics Corporation's 5-year revenue CAGR of +109.0% reflects the sustained expansion pattern. Current YoY growth of +20.2% is above this long-term average.
How is PRCT's revenue distributed by segment?
PRCT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.